Faculty profile

Lisa Wang

Back to faculty

Assistant ProfessorBiostatistics DivisionUniversity of Toronto

Signals and details

Latest papers

Protocol-driven botulinum toxin injections for pediatric neurogenic bladder: long-term continence and bladder outcomes supporting its role as a minimally invasive alternative to augmentation cystoplasty.
World journal of urology · 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD).
JHEP reports : innovation in hepatology · 2026
Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.
Journal for immunotherapy of cancer · 2025

All 103 publications

103 publications.

Protocol-driven botulinum toxin injections for pediatric neurogenic bladder: long-term continence and bladder outcomes supporting its role as a minimally invasive alternative to augmentation cystoplasty.

Rivera KC, Rickard M, Ahmad I, Rajesh Z, Varghese A, Wang L, Chua ME, Lorenzo AJ, Dos Santos J

World journal of urology2026

DOI: 10.1007/s00345-026-06549-0 PMID: 42319465

Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD).

O'Kane GM, Mesci A, Jang RW, Barry A, Bocaya CM, Boukhaled GM, Acton H, Doddington D, Rodrigo R, Chan LML, Noamani B, Harvey H, Elia A, Law R, Prince R, Doherty M, Dodd A, Wong DK, Wang L, Wang BX, Chen EX, Dawson LA, Knox JJ

JHEP reports : innovation in hepatology2026

DOI: 10.1016/j.jhepr.2025.101658 PMID: 41585952

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Roudko V, Del Valle DM, Radkevich E, Kelly G, Hui X, Patel M, Gonzalez-Kozlova E, Tuballes K, Streicher H, Atale S, Wang L, CzinCzin B, Kim-Schulze S, Wistuba II, Haymaker CL, Al-Atrash G, Manyam G, Zhang J, Thompson R, Suarez-Farinas M, Lheureux S, Gnjatic S

Journal for immunotherapy of cancer2025

DOI: 10.1136/jitc-2024-010541 PMID: 40010771

Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.

Richard-Carpentier G, Gupta G, Koraksic C, Cathelin S, Wang L, Bankar A, Davidson M, Gupta V, Maze D, Minden MD, Murphy T, Schimmer AD, Schuh AC, Sibai H, Yee K, DiNardo CD, Brandwein J, McNamara CJ, Chan SM

The Lancet. Haematology2025

DOI: 10.1016/s2352-3026(25)00254-6 PMID: 41075807

Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Alqaisi HA, Cohn DE, Chern JY, Duska LR, Jewell A, Corr BR, Winer IS, Girda E, Crispens MA, Dhani NC, Madariaga A, Grant RC, Malaguti M, Lee C, Bowering V, Wong H, Poothullil A, Speers V, Wang L, Bedard PL, Brady JC, Nixon AB, Chen L, O'Connor C, Zamboni W, McKee T, Moscow JA, Oza AM, Lheureux S

Clinical cancer research : an official journal of the American Association for Cancer Research2025

DOI: 10.1158/1078-0432.ccr-24-3128 PMID: 39836408

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.

Madariaga A, Jivraj N, Soberanis Pina P, Somji F, Truong T, Melwani S, Lovas M, Gogos TA, Sajewycz K, Bhat G, Alqaisi H, Gonzalez-Ochoa E, Veneziani A, Garg V, Dhani NC, Grant R, Bowering V, Oza AM, Wang L, Berlin A, Lheureux S

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2024

DOI: 10.1136/ijgc-2024-005490 PMID: 38821545

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Salawu A, Malone ER, Al-Ezzi E, Genta S, Vornicova O, Wang L, Arones L, Phillips M, Lee J, Watson GA, Gupta AA, Abdul Razak AR

Targeted oncology2024

DOI: 10.1007/s11523-024-01076-7 PMID: 38890222

Corrigendum to Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences: Am J Obstet Gynecol 225 (2021) 658.e1-658.e9/Article 658.

Madariaga A, Bhat G, Wilson MK, Li X, Cyriac S, Bowering V, Hunt W, Gutierrez D, Bonilla L, Kasherman L, McMullen M, Wang L, Ghai S, Dhani NC, Oza AM, Lheureux S

American journal of obstetrics and gynecology2024

DOI: 10.1016/j.ajog.2024.03.039 PMID: 38679558

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.

Chavez JC, Foss FM, William BM, Brammer JE, Smith SM, Prica A, Zain JM, Tuscano JM, Shah H, Mehta-Shah N, Geethakumari PR, Wang BX, Zantinge S, Wang L, Zhang L, Boutrin A, Zhao W, Cheng L, Standifer N, Hewitt L, Enowtambong E, Shao W, Sharma S, Carlesso G, Moscow JA, Siu LL

Clinical cancer research : an official journal of the American Association for Cancer Research2023

DOI: 10.1158/1078-0432.ccr-22-2955 PMID: 36826995

Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.

Hernando-Calvo A, Malone E, Day D, Prawira A, Weinreb I, Yang SYC, Wong H, Rodriguez A, Jennings S, Eliason A, Wang L, Spreafico A, Siu LL, Hansen AR

Cancer medicine2023

DOI: 10.1002/cam4.6589 PMID: 37818869

Profile data last refreshed on July 30, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Lisa Wang

Latest papers

Protocol-driven botulinum toxin injections for pediatric neurogenic bladder: long-term continence and bladder outcomes supporting its role as a minimally invasive alternative to augmentation cystoplasty.

Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD).

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.

Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers.

Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial.

Corrigendum to Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences: Am J Obstet Gynecol 225 (2021) 658.e1-658.e9/Article 658.

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.

Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.

Frequent collaborators

Stephanie Lheureux

Anna Spreafico

Holger Hirte

Sebastien Hotte

Stephen Welch

Ming-Sound Tsao

Xuan Li

Elaine McWhirter

Neesha Dhani

John Kim

David Hedley

Tracy Stockley

Amit Oza

Michael Reedijk

Som Mukherjee

Jennifer Croke

Andrew Hope

John Kuruvilla

Michael Milosevic

Naoto Hirano